NeuroOne’s CEO Talks About 510(k) Clearance Of Evo sEEG Electrodes

 
• By Hannah Daniel

Medtech Insight spoke to Dave Rosa, CEO of NeuroOne, about working with the FDA to get a 510(k) clearance.

• Source: Shutterstock

More from Regulation

More from Policy & Regulation